BOSTON, Sept. 23, 2021 /PRNewswire/ — BIORCHESTRA is a bio-tech company focused on the identification of novel targets in neurodegenerative diseases using RNA-based therapeutics. To access these novel targets, BIOCHESRTRA has also developed a proprietary nanoparticle formulation to deliver RNA-based drugs across the blood-brain barrier in sufficient amounts to be therapeutically effective. In addition, their proprietary exosome-based diagnostic that detects and quantifies markers of neuroinflam
https://apnews.com/press-release/pr-newswire/business-boston-023e4f24c1557851d0ed6d0f0f5b148b
